MBOT

Microbot Medical Inc. [MBOT] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

MBOT Stock Summary

Top MBOT Correlated Resources

MBOT

Top 10 Correlated ETFs

MBOT

Top 10 Correlated Stocks

MBOT

In the News

MBOT Financial details

Company Rating
-
Market Cap
14.54M
Income
-10.67M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
21
Optionable
No
Shortable
Yes
Earnings
15 May 2024
P/E
0.15
Forward P/E
-
PEG
-0.01
P/S
-
P/B
2.28
P/C
-
P/FCF
-1.82
Quick Ratio
5.47
Current Ratio
5.64
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.08
EPS next Y
-
EPS next Q
-
EPS this Y
-107.27%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
28.57%
-
-
-
-
SMA20
-
SMA50
-50%
SMA100
-50%
Inst Own
-
Inst Trans
-
ROA
1248%
ROE
1532%
ROC
-1.47%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.0-4.37
52W High
-74.01%
52W Low
+3.96%
RSI
24
Rel Volume
8.35
Avg Volume
98.01K
Volume
817.96K
Perf Week
9.43%
Perf Month
-27.81%
Perf Quarter
-52.53%
Perf Half Y
-52.31%
-
-
-
-
Beta
1.648
-
-
Volatility
0.03%, 0.16%
Prev Close
10.4%
Price
1.0396
Change
6.03%

Something similar

Top by Market Cap
AMZN
VTSAX
BRK-B
VFINX
BRH.DE
Top Correlated ETFs
KBWD
MVRL
RIET
XCCC
REM
Top Correlated Stocks
ACH
MOS
AMRN
PETS
BBGI
Similar Market Cap
HONBS.HE
FSYD
CNXT
KOSS
EMSV.F

Company Profile

Healthcare Medical - Instruments & Supplies
  • Volume Average 98.01K
  • Market Capitalization 14.54M
  • Employee 21
  • CEO Mr. Harel Gadot
  • Headquarters Hingham,MA,US
  • IPO Date 1992-03-25
  • Website https://www.microbotmedical.com

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.